Satsangi J - Search Results

1

Theodoratou E, Campbell H, Ventham NT, Kolarich D, Pučić-Baković M, Zoldoš V, Fernandes D, Pemberton IK, Rudan I, Kennedy NA, Wuhrer M, Nimmo E, Annese V, McGovern DP, Satsangi J, Lauc G. Theodoratou E, et al. Among authors: satsangi j. Nat Rev Gastroenterol Hepatol. 2014 Oct;11(10):588-600. doi: 10.1038/nrgastro.2014.78. Epub 2014 Jun 10. Nat Rev Gastroenterol Hepatol. 2014. PMID: 24912389 Review.

2

Review article: the genetics of inflammatory bowel disease.

Ahmad T, Satsangi J, McGovern D, Bunce M, Jewell DP. Ahmad T, et al. Among authors: satsangi j. Aliment Pharmacol Ther. 2001 Jun;15(6):731-48. doi: 10.1046/j.1365-2036.2001.00981.x. Aliment Pharmacol Ther. 2001. PMID: 11380312 Free article. Review.

3

Genetics of inflammatory bowel disease: scientific and clinical implications.

Satsangi J, Morecroft J, Shah NB, Nimmo E. Satsangi J, et al. Best Pract Res Clin Gastroenterol. 2003 Feb;17(1):3-18. doi: 10.1053/bega.2002.0349. Best Pract Res Clin Gastroenterol. 2003. PMID: 12617879 Review.

4

NOD2/CARD15 and the Paneth cell: another piece in the genetic jigsaw of inflammatory bowel disease.

Aldhous MC, Nimmo ER, Satsangi J. Aldhous MC, et al. Among authors: satsangi j. Gut. 2003 Nov;52(11):1533-5. doi: 10.1136/gut.52.11.1533. Gut. 2003. PMID: 14570717 Free PMC article. No abstract available.

5

Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.

Walker LJ, Aldhous MC, Drummond HE, Smith BR, Nimmo ER, Arnott ID, Satsangi J. Walker LJ, et al. Among authors: satsangi j. Clin Exp Immunol. 2004 Mar;135(3):490-6. doi: 10.1111/j.1365-2249.2003.02392.x. Clin Exp Immunol. 2004. PMID: 15008984 Free PMC article.

6

Molecular genetics of Crohn's disease.

Russell RK, Nimmo ER, Satsangi J. Russell RK, et al. Among authors: satsangi j. Curr Opin Genet Dev. 2004 Jun;14(3):264-70. doi: 10.1016/j.gde.2004.04.004. Curr Opin Genet Dev. 2004. PMID: 15172669 Review.

7

Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease.

Smith BR, Arnott ID, Drummond HE, Nimmo ER, Satsangi J. Smith BR, et al. Among authors: satsangi j. Inflamm Bowel Dis. 2004 Sep;10(5):521-8. doi: 10.1097/00054725-200409000-00005. Inflamm Bowel Dis. 2004. PMID: 15472511

8

Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.

Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, Satsangi J. Arnott ID, et al. Among authors: satsangi j. Am J Gastroenterol. 2004 Dec;99(12):2376-84. doi: 10.1111/j.1572-0241.2004.40417.x. Am J Gastroenterol. 2004. PMID: 15571586

9

Toll-like receptor 4 gene in IBD: further evidence for genetic heterogeneity in Europe.

Arnott ID, Ho GT, Nimmo ER, Satsangi J. Arnott ID, et al. Among authors: satsangi j. Gut. 2005 Feb;54(2):308; author reply 309. Gut. 2005. PMID: 15647200 Free PMC article. No abstract available.

10

Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis.

Ho GT, Nimmo ER, Tenesa A, Fennell J, Drummond H, Mowat C, Arnott ID, Satsangi J. Ho GT, et al. Among authors: satsangi j. Gastroenterology. 2005 Feb;128(2):288-96. doi: 10.1053/j.gastro.2004.11.019. Gastroenterology. 2005. PMID: 15685540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

364 results

Search Page